FDA Approved: RYANODEX DANTROLENE SODIUM — Supplemental Application (Eagle Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Ryanodex Dantrolene Sodium (dantrolene sodium) submitted by Eagle Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Hyperthermia

Drugs mentioned

• RYANODEX DANTROLENE SODIUM (DANTROLENE SODIUM)

Snippet

SUPPL AP for RYANODEX DANTROLENE SODIUM (DANTROLENE SODIUM)